Mode
Text Size
Log in / Sign up
N/A N=25 Treatment

TriActive+ Radiofrequency (RF) for Non-invasive Treatment of Wrinkles & Rhytides

Wrinkles · Rhytides

Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcome: Primary: Fitzpatrick Classification of Wrinkling and Degree of Elastosis. — 5.6; 5.56; 5.36; 5.32 Fitzpatrick Classification Scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
TriActive+ RF (Device)
Age
Adult · 30+ yrs
Sex
All
Sponsor
Deka Medical, Inc.
Primary completion
Apr 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Fitzpatrick Classification of Wrinkling and Degree of Elastosis.
5.6; 5.56; 5.36; 5.32; 4.88

Summary

The study objective is to evaluate the safety and efficacy of a radiofrequency (RF) source, the TriActive+ RF handpiece, for treatment of wrinkles and rhytides after multiple treatments. The primary endpoint is observation of changes to the surface by visual and photographic analysis. Secondary endpoints: measurement of patient satisfaction and comfort of the treatment and the measurement of adverse events.

Eligibility Criteria

Inclusion Criteria

  • Informed consent agreement signed by the subject.
  • Healthy male or female subjects 30-60 years of age.
  • Having at least two facial sub-areas (left peri-orbital, right peri-orbital or peri-oral) with visible lines/wrinkles and elastosis, which correlate to a score of 2-6 on the Fitzpatrick Classification of Wrinkling and Degree of Elastosis.
  • Willingness to follow the treatment and follow-up schedule and the post-treatment care.
  • For female candidates - post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study (i.e., oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide, or abstinence).

Exclusion Criteria

  • Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breastfeeding.
  • Having any active electrical implant anywhere in the body, such as a pacemaker or an internal defibrillator.
  • Having a permanent implant in the treated area, such as metal plates and screws, or an injected chemical substance.
  • Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
  • Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-containing agents) one week before and after each treatment session.
  • Use of retinoids, antioxidants or skin nourishing supplements within 1 month of treatment or during the study.
  • Having received a facial within 1 month of treatment or during the study.
  • Having received a facial dermabrasion or chemical peel treatment within 2 months of treatment or during the study.
  • Having received treatment with light, RF or other devices in the treated area within 6 months of treatment or during the study.
  • Having received Botox in the treated area within 6 months of treatment or during the study.
  • Having received collagen/Hyaluronic Acid (HA) in the treated area within a year of treatment or during the study.
  • Having undergone a resurfacing procedure, face lift or eyelid surgery within a year of treatment or during the study.
  • Having undergone any other surgery in the treated area within 6 months of treatment (or more if skin has not healed completely) or during the study.
  • Having ever received fat injections or other methods of augmentation with injected or implanted material in the treated area or planning to during the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01460927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search